Denise McKinney

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

Bernhards Ogutu, Odika J. Apollo, Denise McKinney et al. · PLoS ONE · 2009 · 343 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental<i>Plasmodium falciparum</i>Malaria

Kent E. Kester, Denise McKinney, Nadia Tornieporth et al. · The Journal of Infectious Diseases · 2001 · 270 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

Kent E. Kester, Denise McKinney, Nadia Tornieporth et al. · Vaccine · 2007 · 106 citations

Veterinary Medicine, Infectious Diseases, Pharmacokinetics +15

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

José A. Stoute, Joash Gombe, Mark R. Withers et al. · Vaccine · 2005 · 100 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children

Mark R. Withers, Denise McKinney, Bernhards Ogutu et al. · PLoS Clinical Trials · 2006 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17